{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T17:41:39Z","timestamp":1780335699504,"version":"3.54.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"26","license":[{"start":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T00:00:00Z","timestamp":1625184000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Tranexamic acid (TXA) is an antifibrinolytic agent used to reduce bleeding in major surgical procedures. This study evaluates the efficacy and safety of the systemic and topical intra-articular administration of TXA in total hip arthroplasty (THA).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Patients (N\u200a=\u200a123) scheduled for primary unilateral THA were divided into 3 treatment groups: control group; TXA, systemic, repeated 1\u200ag bolus; TXA, topically intra-articularly, 2\u200ag in 50\u200amL saline. Primary readouts used were intra- and postoperative bleeding, transfusion requirement, postoperative hemoglobin levels and complications.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Both systemic and topical intra-articular TXA administrations decreased bleeding and transfusion requirements. Topical intra-articular use of TXA led to the reduction in intraoperative and postoperative bleeding and affected hemoglobin levels compared with control. Systemic administration of TXA led to a significant reduction of postoperative bleeding and transfusion rate compared with control and was not different in efficacy and complication incidence when compared to topical administration of TXA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The use of TXA to reduce blood loss and transfusion requirements in THA is an effective and safe concept in practice. The dose of 2\u200ag TXA topically intra-articularly and a repeated bolus of 1\u200ag TXA systematic led to lower intra- and postoperative bleeding and a significantly lower transfusion rate than the control group. Topical intra-articular TXA administration could be a reasonable alternative in high-risk patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000026565","type":"journal-article","created":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T14:12:03Z","timestamp":1625062323000},"page":"e26565","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":16,"title":["Evaluation of efficacy and safety of systemic and topical intra-articular administration of tranexamic acid in primary unilateral total hip arthroplasty"],"prefix":"10.1097","volume":"100","author":[{"given":"Masaryk","family":"Juraj","sequence":"first","affiliation":[{"name":"Orthopedic Department of the University Hospital Trencin, Legion\u00e1rska 28, 911 71 Tren\u010d\u00edn"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vidan","family":"Jaroslav","sequence":"additional","affiliation":[{"name":"Orthopedic Department of the University Hospital Trencin, Legion\u00e1rska 28, 911 71 Tren\u010d\u00edn"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4515-5693","authenticated-orcid":false,"given":"Andrea","family":"Ga\u017eov\u00e1","sequence":"additional","affiliation":[{"name":"Institute of Pharmacology and Clinical Pharmacology, Faculty of Medicine Comenius University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viera","family":"\u017dufkov\u00e1","sequence":"additional","affiliation":[{"name":"Department of Languages, Faculty of Pharmacy, Comenius University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e1n","family":"Kyselovi\u010d","sequence":"additional","affiliation":[{"name":"V. Department of Internal Medicine, Faculty of Medicine Comenius University, Bratislava, Slovakia."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"\u0160te\u0148o","sequence":"additional","affiliation":[{"name":"II. Department of Orthopedics and Traumatology, University Hospital and Faculty of Medicine, Comenius University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,7,2]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"02","DOI":"10.2106\/00004623-199901000-00002","article-title":"An analysis of blood management in patients having a total hip or knee arthroplasty","volume":"81","author":"Bierbaum","year":"1999","journal-title":"J Bone Joint Surg Am"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1136\/jcp.33.Suppl_14.41","article-title":"Clinical pharmacology of aminocaproic and tranexamic acids","volume":"14","author":"Nilsson","year":"1980","journal-title":"J Clin Pathol Suppl (R Coll Pathol)"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1056\/NEJM199807233390407","article-title":"Hemostatic drugs","volume":"339","author":"Mannucci","year":"1998","journal-title":"N Engl J Med"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4103\/1658-354X.109803","article-title":"Role of tranexamic acid in reducing postoperative blood loss and transfusion requirement in patients undergoing hip and femoral surgeries","volume":"7","author":"Vijay","year":"2013","journal-title":"Saudi J Anaesth"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"e0206480","DOI":"10.1371\/journal.pone.0206480","article-title":"Optimal use of tranexamic acid for total hip arthroplasty: a network meta-analysis","volume":"13","author":"Yoon","year":"2018","journal-title":"PLoS One"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.thromres.2014.11.012","article-title":"Tranexamic acid\u2014an old drug still going strong and making a revival","volume":"135","author":"Tengborn","year":"2015","journal-title":"Tromb Res"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.arth.2019.08.015","article-title":"Tranexamic acid administration is not associated with an increase in complications in high-risk patients undergoing primary total knee or total hip arthroplasty: a retrospective case-control study of 38,220 patients","volume":"35","author":"Porter","year":"2020","journal-title":"J Arthroplasty"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.2147\/DDDT.S175407","article-title":"Intravenous tranexamic acid use in revision total joint arthroplasty: a meta-analysis","volume":"12","author":"Kuo","year":"2018","journal-title":"Drug Des Dev Ther"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1016\/j.arth.2018.08.002","article-title":"Tranexamic acid use in total joint arthroplasty: the clinical practice guidelines endorsed by the American Association of Hip and Knee Surgeons, American Society of Regional Anesthesia and Pain Medicine, American Academy of Orthopaedic Surgeons, Hip Society, and Knee Society","volume":"33","author":"Fillingham","year":"2018","journal-title":"J Arthroplasty"},{"key":"R10-20250504","first-page":"824","article-title":"Tranexamic acid prophylaxis in hip and knee joint replacement","volume":"114","author":"Goldstein","year":"2017","journal-title":"Dtsch Arztebl Int"},{"issue":"(suppl 3)","key":"R11-20250504","first-page":"S17","article-title":"Does tranexamic acid reduce blood transfusion following surgery for inter-trochanteric fracture? A randomized control trial","volume":"65","author":"Mohib","year":"2016","journal-title":"J Pak Med Assoc"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1213\/00000539-200011000-00014","article-title":"Tranexamic acid reduces blood loss in total hip replacement surgery","volume":"91","author":"Ekb\u00e4ck","year":"2000","journal-title":"Anesth Analg"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s13018-018-0948-1","article-title":"Comparative effectiveness and safety of tranexamic acid plus diluted epinephrine to control blood loss during total hip arthroplasty: a meta-analysis","volume":"13","author":"Wang","year":"2018","journal-title":"J Orthop Surg Res"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"254","DOI":"10.55095\/achot2017\/040","article-title":"Local application of tranexamic acid in total hip arthroplasty decreases blood loss and consumption of blood transfusion","volume":"84","author":"Lostak","year":"2017","journal-title":"Acta Chir Orthop Traumatol Cech"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00264-013-1787-7","article-title":"Repeat-dose intravenous tranexamic acid further decreases blood loss in total knee arthroplasty","volume":"37","author":"Iwai","year":"2013","journal-title":"Int Orthop"},{"key":"R17-20250504","first-page":"320","article-title":"Recommendations for the transfusion management of patients in the peri-operative period. III. The post-operative period","volume":"9","author":"Liumbruno","year":"2011","journal-title":"Blood Transfus"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"e12270","DOI":"10.1097\/MD.0000000000012270","article-title":"The efficacy of oral versus intravenous tranexamic acid in reducing blood loss after primary total knee and hip arthroplasty: a meta-analysis","volume":"97","author":"Wang","year":"2018","journal-title":"Medicine"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s12891-019-2715-9","article-title":"Intraarticular use of tranexamic acid reduces blood loss and transfusion rate after primary total knee arthroplasty","volume":"20","author":"Tille","year":"2019","journal-title":"BMC Musculoskelet Disord"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"118","DOI":"10.55095\/achot2019\/016","article-title":"[Evaluation of efficacy of systemic administration of tranexamic acid (exacyl) in total hip and knee arthroplasty\u2014prospective cohort study]","volume":"86","author":"Mannov\u00e1","year":"2019","journal-title":"Acta Chir Orthop Traumatol Cech"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.1016\/j.arth.2018.03.031","article-title":"The safety of tranexamic acid in total joint arthroplasty: a direct meta-analysis","volume":"33","author":"Fillingham","year":"2018","journal-title":"J Arthroplasty"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jos.2018.09.004","article-title":"Dose optimization of topical tranexamic acid for primary total hip arthroplasty: a prospective cohort study","volume":"24","author":"Yamaguchi","year":"2019","journal-title":"J Orthop Sci"},{"key":"R23-20250504","first-page":"77","article-title":"Tranexamic acid and orthopedic surgery-the search for the holy grail of blood conservation","volume":"3","author":"Danninger","year":"2015","journal-title":"Ann Transl Med"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"04","DOI":"10.4172\/2329-6887.1000171","article-title":"Systematic review of tranexamic acid adverse reactions","volume":"3","author":"Calapai","year":"2015","journal-title":"J Pharmacovigilance"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1213\/XAA.0000000000000667","article-title":"Acute coronary artery thrombus after tranexamic acid during total shoulder arthroplasty in a patient with coronary stents: a case report","volume":"10","author":"Bridges","year":"2018","journal-title":"A A Pract"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000026565","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T05:35:36Z","timestamp":1746336936000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000026565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,2]]},"references-count":24,"journal-issue":{"issue":"26","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000026565","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,2]]},"assertion":[{"value":"2020-11-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}